The global manufacturing execution system market size is estimated to be worth USD 3.99 billion in 2024 and is anticipated to reach USD 20.46 billion by 2035 at a CAGR of 16.02% during the forecast period.
Manufacturing Execution System providers in healthcare market is the rising realm amongst stakeholders in pursuit to connect, monitor and control the complex manufacturing process. Every year, the healthcare industry generates a massive amount of data. In fact, the healthcare data currently constitutes around 30% share of the global data volume. Further, it is estimated that, by 2025, the data generated via the healthcare sector will rise at a compound annual growth rate of 36%.
According to industry experts, MES has the potential to reduce 10%-30% of the overall production cost depending on the type of industry. It has further been observed that companies are increasingly adopting cloud-based manufacturing execution system, to overcome the challenges associated with growing complexity of processes and global expansion of businesses. Specifically, cloud-based MES integrates real-time information of different production floors and promotes collaboration. Driven by the ongoing innovation in the industry, as well as the rise in demand for automated solutions, the manufacturing execution system providers market for the healthcare sector is likely to witness positive growth over the coming years.
The market is characterized by the presence of very large companies (more than 10,000 employees), large players (501-10,000 employees), mid-sized companies (51-500 employees) and small companies (less than 50 employees). It is worth mentioning that mid-sized companies are pre-dominantly contributing to this field. Notably, the industry has also witnessed contributions from several very large firms such as (in alphabetical order) Dassault Systèmes, Emerson, Honeywell and Samsung SDS.
During our research, we observed that majority of the manufacturing execution system providers offer cloud-based solutions, followed by on-premises. Examples of the providers offering on-premises solutions include Aveva, Rockwell Automation and Trunovate. Furthermore, majority (87%) manufacturing execution system providers offer MES in subscription-based license type followed by providers offering MES in both perpetual and subscription-based model.
It is worth mentioning that pharmaceutical and lifescience / biotechnology companies are its most prominent end users. In addition, the company has signed partnerships during the period 2018-2022. Examples of other prominent small players in this domain include (arranged in decreasing order of competitiveness) GE Digital and Aveva. It is also worth mentioning that a majority of firms in this peer group are based in North America.
Value creation framework includes an insightful depiction for implementation of several advanced tools and technologies at different production steps, such as performance analysis, data storage, document control and process tracking which can assist providers to address unmet needs associated in this domain. Additionally, it provides a detailed analysis on ease of implementation, associated risk and value creation in integrating such tools / technologies, based on the trends highlighted in published literature and patents.
The value creation framework includes four key tools and technologies that can assist MES providers to enhance their portfolio, based on several relevant parameters. These are as follows:
- Artificial Intelligence
- Cloud Computing
- Internet of Things (IoT)
- Machine Learning
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html
Browse More Related Reports
https://pad.stuvus.uni-stuttgart.de/s/GxrOPSED1
https://hedgedoc.eclair.ec-lyon.fr/s/0nq9v2S8S
https://pad.ufc.tu-dortmund.de/s/-y0o6q3iC
https://pad.stuve.uni-ulm.de/s/CZ6qTPE1P
https://bpcnitrkl.in/members/gayle786/
https://hedge.fachschaft.informatik.uni-kl.de/s/grkB9Wtao
https://www.wowonder.xyz/read-blog/103573
https://ai.ceo/read-blog/196445
https://sites.google.com/view/cancer-biomarker/home
https://gargvidhi.copiny.com/idea/details/id/205183
https://hackmd.io/@Xdjgm_dJRIuJG-6hOg1nlg/BJAc9BZ11e
https://garg.muragon.com/entry/11.html
https://scrapbox.io/garg/Cancer_Biomarker__Market_-_Current_Impact_to_Make_Big_Changes_by_2035
https://gargvidhi123.pixnet.net/blog/post/163965151
https://blog.wenxuecity.com/myblog/81712/202410/4735.html
https://yamcode.com/garg-66347
https://youdontneedwp.com/garg/my-new-post-22bb4d9b-c6ad-427a-8b83-3001c2fe5046
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
+1 (415) 800 3415
